Decoding the Mystery: Why Does Mounjaro Cause Headaches in GLP, 1 Weight Loss Treatments? Written by Bolt Pharmacy Published on 17/4/2026 Embarking on a weight loss journey can often feel overwhelming, especially when trying to understand the finer details of your chosen method. In this Bolt Pharmacy blog post, we delve into the world of […]
Tag Archives: scientific research
Can I Take Mounjaro 2 Days Early? UK Dosing Guidelines Written by Bolt Pharmacy Published on 27/7/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management in eligible adults. Many patients wonder whether they can take Mounjaro 2 days early if their schedule changes or they’ve […]
Missed Mounjaro Dose? What Happens & How to Resume Safely Written by Bolt Pharmacy Published on 27/7/2026 Missing a weekly dose of Mounjaro (tirzepatide) is a common concern for people managing type 2 diabetes. Whilst occasional missed doses are unlikely to cause serious harm, understanding the correct approach to resuming treatment is essential for maintaining […]
Mounjaro and Water Intake: Essential UK Hydration Guidance Written by Bolt Pharmacy Published on 27/7/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes mellitus, working as a dual GIP and GLP-1 receptor agonist. Whilst the medication does not directly affect fluid balance, its gastrointestinal effects—including nausea, vomiting, and […]
Does Mounjaro Affect Iron Levels? UK Evidence and Guidance Written by Bolt Pharmacy Published on 3/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Many patients wonder whether Mounjaro affects iron levels, particularly given its gastrointestinal effects and impact on appetite. Current […]
Mounjaro and Gum Disease: What’s the Link? Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Whilst people with diabetes face increased risk of periodontal disease, there is no established direct link between Mounjaro and gum […]
Mounjaro After Gallbladder Removal: UK Safety Guide Written by Bolt Pharmacy Published on 5/5/2026 Mounjaro (tirzepatide) can generally be taken safely after gallbladder removal, with no absolute contraindication for post-cholecystectomy patients. This dual GLP-1 and GIP receptor agonist, licensed in the UK for type 2 diabetes management, requires careful consideration of your individual digestive function […]
What Colour Is Mounjaro? UK Pen Identification Guide Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management. The pre-filled pens use a colour-coded system to help identify different dosage strengths—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, […]
Mounjaro and Skin Tags: Effects, Management and Advice Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with comorbidities. As patients experience substantial weight reduction, many notice various skin changes, including concerns […]
How to Wean Off Mounjaro: Safe Discontinuation Guide Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes management. Whilst effective for glycaemic control, various medical, practical, or personal circumstances may necessitate discontinuation. Understanding how to wean off Mounjaro safely […]